Watchlist Price Alert

Immuneering Corporation (IMRX)

NASDAQ: IMRX · Real-Time Price · USD

1.24

-0.05 (-3.88%)

At close: May 02, 2025, 3:59 PM

1.27

2.83%

After-hours: May 02, 2025, 05:46 PM EDT

Immuneering Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-61.04M	-53.47M	-50.51M	-33.54M	-17.04M	-7.71M
Depreciation & Amortization	n/a	352.08K	796.79K	159.07K	79.31K	18.08K
Stock-Based Compensation	6.5M	5.73M	4.06M	1.8M	1.09M	596.63K
Other Working Capital	-813.24K	119.84K	-276.56K	751.1K	357.58K	-465K
Other Non-Cash Items	461.05K	-601.59K	-166.21K	130.24K	349.96K	1.48M
Deferred Income Tax	n/a	n/a	n/a	-307.49K	-349.96K	739.03K
Change in Working Capital	-925.38K	-974.64K	1.72M	900.42K	1.25M	437.13K
Operating Cash Flow	-55M	-48.97M	-44.1M	-30.85M	-14.62M	-4.44M
Capital Expenditures	-84.88K	-342.75K	-742.48K	-60.79K	-53.41K	-20.53K
Cash Acquisitions	n/a	n/a	-41.83M	70.35K	n/a	n/a
Purchase of Investments	n/a	-44.66M	-50.1M	-75.63M	n/a	n/a
Sales Maturities Of Investments	n/a	52.3M	92.68M	75.62M	n/a	n/a
Other Investing Acitivies	26.43M	n/a	41.83M	-75.62M	n/a	n/a
Investing Cash Flow	26.43M	7.3M	41.83M	-75.62M	-53.41K	-20.53K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	3.83M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	5.3M	241.07K	19K	-842.76K	n/a	-3.88M
Financial Cash Flow	5.3M	28.44M	19K	144.26M	37.98M	17.17M
Net Cash Flow	-23.26M	-13.23M	-2.25M	37.8M	23.31M	12.71M
Free Cash Flow	-55.08M	-49.31M	-44.84M	-30.91M	-14.67M	-4.46M